BIOTRICITY INC. Share-based Payment Arrangement, Expense
BIOTRICITY INC. (BTCY) reported Share-based Payment Arrangement, Expense of $1.52 million for the 12-month period ending 2021-03-31, per its 10-K filed 2021-06-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-06-22
- BIOTRICITY INC. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $190.93K, a 53.02% increase year-over-year.
- BIOTRICITY INC. share-based payment arrangement, expense for the quarter ending 2020-06-30 was $236.04K, a 23.55% decline year-over-year.
- BIOTRICITY INC. share-based payment arrangement, expense for the quarter ending 2020-03-31 was $1.84M, a 396.02% increase year-over-year.
- BIOTRICITY INC. share-based payment arrangement, expense for the quarter ending 2019-12-31 was $124.77K, a 60.58% decline year-over-year.
- BIOTRICITY INC. share-based payment arrangement, expense for fiscal 2021 was $1.52M, a 36.37% decline from fiscal 2020.
- BIOTRICITY INC. share-based payment arrangement, expense for fiscal 2020 was $2.39M, a 67.29% increase from fiscal 2019.
- BIOTRICITY INC. share-based payment arrangement, expense for fiscal 2019 was $1.43M, a 19.16% increase from fiscal 2018.
- BIOTRICITY INC. share-based payment arrangement, expense for fiscal 2018 was $1.20M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2021-03-31 | $1.52M 10-K · filed 2021-06-22 | |||
| 2020-09-30 | $190.93K 10-Q · filed 2020-11-13 | $426.98K 10-Q · filed 2020-11-13 | $2.26M derived: sum of 3 quarters · filed 2021-06-22 | $2.39M derived: sum of 4 quarters · filed 2021-06-22 |
| 2020-06-30 | $236.04K 10-Q · filed 2020-08-14 | $2.07M derived: sum of 2 quarters · filed 2021-06-22 | $2.20M derived: sum of 3 quarters · filed 2021-06-22 | $2.32M derived: sum of 4 quarters · filed 2021-06-22 |
| 2020-03-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-22 | $1.96M derived: sum of 2 quarters · filed 2021-06-22 | $2.08M derived: sum of 3 quarters · filed 2021-06-22 | $2.39M 10-K · filed 2021-06-22 |
| 2019-12-31 | $124.77K 10-Q · filed 2020-02-14 | $249.55K derived: sum of 2 quarters · filed 2020-11-13 | $558.30K 10-Q · filed 2020-02-14 | $928.25K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-09-30 | $124.77K 10-Q · filed 2020-11-13 | $433.53K 10-Q · filed 2020-11-13 | $803.48K derived: sum of 3 quarters · filed 2020-11-13 | $1.12M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $308.75K 10-Q · filed 2020-08-14 | $678.71K derived: sum of 2 quarters · filed 2020-08-14 | $995.25K derived: sum of 3 quarters · filed 2020-08-14 | $1.42M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $369.95K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-15 | $686.50K derived: sum of 2 quarters · filed 2020-07-15 | $1.11M derived: sum of 3 quarters · filed 2020-07-15 | $1.43M 10-K · filed 2020-07-15 |
| 2018-12-31 | $316.54K 10-Q · filed 2020-02-14 | $737.57K derived: sum of 2 quarters · filed 2020-02-14 | $1.06M 10-Q · filed 2020-02-14 | |
| 2018-09-30 | $421.03K 10-Q · filed 2019-11-14 | $744.17K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $389.06K 10-Q · filed 2019-08-15 | |||
| 2018-03-31 | $1.20M 10-K · filed 2019-07-16 |